Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics

Chen-Hsun Ho, Chia-Chang Wu, Chao-Chuan Wu, Yao-Chou Tsai

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

AIMS:We aimed to evaluate the safety and feasibility of laparoscopic total extraperitoneal (TEP) inguinal hernia repair in patients with the continuation of their antithrombotic agents.SETTINGS AND DESIGN:This was prospective cohort study.MATERIALS AND METHODS:A total of 115 patients who underwent TEP inguinal hernia repair between January 2015 and September 2016 were included in the analysis. Seventeen patients continued their antithrombotics (antithrombotic group); the other 98 had not been on antithrombotics (control group).STATISTICAL ANALYSIS USED:The analysis was performed by using Mann-Whitney U-test, Chi-square or Fisher's exact test.RESULTS:The antithrombotic group had a greater mean age (65.9 ± 8.0 vs. 57.7 ± 13.6, P = 0.002) and higher prevalence of hypertension (64.7% vs. 33.7%, P = 0.015), cardiovascular diseases (64.7% vs. 7.1%, P < 0.001), atrial fibrillation (23.5% vs. 0, P < 0.001), ischaemic heart disease (35.3% vs. 0, P < 0.001) and the American Society of Anaesthesiologists ≥2 (94.1% vs. 81.6%, P = 0.005). The operation time for the antithrombotic group was longer than that of the control group (92.06 ± 32.81 min vs. 72.33 ± 20.99 min, P = 0.015). None experienced conversion to open surgery in either group. There was no difference in the post-operative complications (29.4% vs. 28.6%) and sero-haematoma formation (23.5% vs. 11.1%). The analgesic requirement, hospital stays (23.72 ± 7.74 vs. 22.35 ± 10.33 h) and the time for return to normal daily activity (3.56 ± 1.74 vs. 3.63 ± 1.90) were not statistically different between the two groups. None in either group experienced major cardiovascular events within 30 days.CONCLUSIONS:Laparoscopic TEP inguinal hernia repair can be safely performed in patients with the continuation of their antithrombotic agents in experienced hands.
原文英語
期刊Journal of Minimal Access Surgery
DOIs
出版狀態打印前電子出版 - 八月 7 2018

指紋

Inguinal Hernia
Herniorrhaphy
Fibrinolytic Agents
Conversion to Open Surgery
Control Groups
Nonparametric Statistics
Hematoma
Atrial Fibrillation
Myocardial Ischemia
Analgesics
Length of Stay
Cohort Studies
Cardiovascular Diseases
Prospective Studies
Hypertension
Safety

Keywords

  • Anticoagulant
  • antiplatelet
  • antithrombotic
  • inguinal hernia
  • laparoscopic

引用此文

@article{295d6ae1f8ec4ec8a098a57f173866c2,
title = "Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics",
abstract = "Aims: We aimed to evaluate the safety and feasibility of laparoscopic total extraperitoneal (TEP) inguinal hernia repair in patients with the continuation of their antithrombotic agents.Settings and Design: This was prospective cohort study.Materials and Methods: A total of 115 patients who underwent TEP inguinal hernia repair between January 2015 and September 2016 were included in the analysis. Seventeen patients continued their antithrombotics (antithrombotic group); the other 98 had not been on antithrombotics (control group).Statistical Analysis Used: The analysis was performed by using Mann-Whitney U-test, Chi-square or Fisher's exact test.Results: The antithrombotic group had a greater mean age (65.9 ± 8.0 vs. 57.7 ± 13.6, P = 0.002) and higher prevalence of hypertension (64.7{\%} vs. 33.7{\%}, P = 0.015), cardiovascular diseases (64.7{\%} vs. 7.1{\%}, P < 0.001), atrial fibrillation (23.5{\%} vs. 0, P < 0.001), ischaemic heart disease (35.3{\%} vs. 0, P < 0.001) and the American Society of Anaesthesiologists ≥2 (94.1{\%} vs. 81.6{\%}, P = 0.005). The operation time for the antithrombotic group was longer than that of the control group (92.06 ± 32.81 min vs. 72.33 ± 20.99 min, P = 0.015). None experienced conversion to open surgery in either group. There was no difference in the post-operative complications (29.4{\%} vs. 28.6{\%}) and sero-haematoma formation (23.5{\%} vs. 11.1{\%}). The analgesic requirement, hospital stays (23.72 ± 7.74 vs. 22.35 ± 10.33 h) and the time for return to normal daily activity (3.56 ± 1.74 vs. 3.63 ± 1.90) were not statistically different between the two groups. None in either group experienced major cardiovascular events within 30 days.Conclusions: Laparoscopic TEP inguinal hernia repair can be safely performed in patients with the continuation of their antithrombotic agents in experienced hands.",
keywords = "Anticoagulant, antiplatelet, antithrombotic, inguinal hernia, laparoscopic",
author = "Chen-Hsun Ho and Chia-Chang Wu and Chao-Chuan Wu and Yao-Chou Tsai",
year = "2018",
month = "8",
day = "7",
doi = "10.4103/jmas.JMAS_128_18",
language = "English",
journal = "Journal of Minimal Access Surgery",
issn = "0972-9941",
publisher = "Medknow Publications and Media Pvt. Ltd",

}

TY - JOUR

T1 - Laparoscopic total extraperitoneal inguinal hernia repair is safe and feasible in patients with continuation of antithrombotics

AU - Ho, Chen-Hsun

AU - Wu, Chia-Chang

AU - Wu, Chao-Chuan

AU - Tsai, Yao-Chou

PY - 2018/8/7

Y1 - 2018/8/7

N2 - Aims: We aimed to evaluate the safety and feasibility of laparoscopic total extraperitoneal (TEP) inguinal hernia repair in patients with the continuation of their antithrombotic agents.Settings and Design: This was prospective cohort study.Materials and Methods: A total of 115 patients who underwent TEP inguinal hernia repair between January 2015 and September 2016 were included in the analysis. Seventeen patients continued their antithrombotics (antithrombotic group); the other 98 had not been on antithrombotics (control group).Statistical Analysis Used: The analysis was performed by using Mann-Whitney U-test, Chi-square or Fisher's exact test.Results: The antithrombotic group had a greater mean age (65.9 ± 8.0 vs. 57.7 ± 13.6, P = 0.002) and higher prevalence of hypertension (64.7% vs. 33.7%, P = 0.015), cardiovascular diseases (64.7% vs. 7.1%, P < 0.001), atrial fibrillation (23.5% vs. 0, P < 0.001), ischaemic heart disease (35.3% vs. 0, P < 0.001) and the American Society of Anaesthesiologists ≥2 (94.1% vs. 81.6%, P = 0.005). The operation time for the antithrombotic group was longer than that of the control group (92.06 ± 32.81 min vs. 72.33 ± 20.99 min, P = 0.015). None experienced conversion to open surgery in either group. There was no difference in the post-operative complications (29.4% vs. 28.6%) and sero-haematoma formation (23.5% vs. 11.1%). The analgesic requirement, hospital stays (23.72 ± 7.74 vs. 22.35 ± 10.33 h) and the time for return to normal daily activity (3.56 ± 1.74 vs. 3.63 ± 1.90) were not statistically different between the two groups. None in either group experienced major cardiovascular events within 30 days.Conclusions: Laparoscopic TEP inguinal hernia repair can be safely performed in patients with the continuation of their antithrombotic agents in experienced hands.

AB - Aims: We aimed to evaluate the safety and feasibility of laparoscopic total extraperitoneal (TEP) inguinal hernia repair in patients with the continuation of their antithrombotic agents.Settings and Design: This was prospective cohort study.Materials and Methods: A total of 115 patients who underwent TEP inguinal hernia repair between January 2015 and September 2016 were included in the analysis. Seventeen patients continued their antithrombotics (antithrombotic group); the other 98 had not been on antithrombotics (control group).Statistical Analysis Used: The analysis was performed by using Mann-Whitney U-test, Chi-square or Fisher's exact test.Results: The antithrombotic group had a greater mean age (65.9 ± 8.0 vs. 57.7 ± 13.6, P = 0.002) and higher prevalence of hypertension (64.7% vs. 33.7%, P = 0.015), cardiovascular diseases (64.7% vs. 7.1%, P < 0.001), atrial fibrillation (23.5% vs. 0, P < 0.001), ischaemic heart disease (35.3% vs. 0, P < 0.001) and the American Society of Anaesthesiologists ≥2 (94.1% vs. 81.6%, P = 0.005). The operation time for the antithrombotic group was longer than that of the control group (92.06 ± 32.81 min vs. 72.33 ± 20.99 min, P = 0.015). None experienced conversion to open surgery in either group. There was no difference in the post-operative complications (29.4% vs. 28.6%) and sero-haematoma formation (23.5% vs. 11.1%). The analgesic requirement, hospital stays (23.72 ± 7.74 vs. 22.35 ± 10.33 h) and the time for return to normal daily activity (3.56 ± 1.74 vs. 3.63 ± 1.90) were not statistically different between the two groups. None in either group experienced major cardiovascular events within 30 days.Conclusions: Laparoscopic TEP inguinal hernia repair can be safely performed in patients with the continuation of their antithrombotic agents in experienced hands.

KW - Anticoagulant

KW - antiplatelet

KW - antithrombotic

KW - inguinal hernia

KW - laparoscopic

U2 - 10.4103/jmas.JMAS_128_18

DO - 10.4103/jmas.JMAS_128_18

M3 - Article

C2 - 30106020

JO - Journal of Minimal Access Surgery

JF - Journal of Minimal Access Surgery

SN - 0972-9941

ER -